Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06448962
Status:
COMPLETED
Last Update Posted:
2024-06-07
First Post:
2024-06-03
Brief Title:
Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022
Sponsor:
Organization:
Addpharma Inc